Agius, R., Mizzi, C., Buttigieg, M., Vella Szijj, J., & Azzopardi, L. M. (2025). Pharmacist‐managed therapeutic drug monitoring service in an intensive care unit. Intensive Care Medicine Experimental, 13(1), 000463, 234.
Borg J, Wirth F, Azzopardi LM. Development and application of a toolkit for community pharmacist-led review of patients with diabetes. Journal of the American College of Clinical Pharmacy. 2025
Falzon, S., Galea, N., Pham, J. T., Grech, L., & Azzopardi, L. M. (2025). Implementation of a pharmaceutical care model within paediatric oncology. Journal of Oncology Pharmacy Practice, 10781552251350553, 1-8.
Farrugia, L., Azzopardi, L. M., Debattista, J., & Abela, C. (2025). medicX-KG: a knowledge graph for pharmacists’ drug information needs. Journal of Biomedical Semantics, 16(1), 11.
Maduelosi, B. I., Szijj, D. J. V., & Serracino-Inglott, P. (2025). The Impact of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) in Healthcare: A Narrative Review. International Journal of Research and Innovation in Applied Science, 10(6), 1761-1772.
Okuyan, B., Henman, M. C., Paudyal, V., Weidmann, A. E., Cadogan, C., Hazen, A.,...Stewart, D. (2025). Research priorities of the European Society of Clinical Pharmacy (ESCP): a questionnaire-based study. International Journal of Clinical Pharmacy, 1-14.
Ruba, J. B., Vella-Szijj, J., & Serracino-Inglott, A. (2025). Establishing Special Interest Groups (SIGs) as a conceptual educational tool to enhance competencies in pharmaceutical scenarios. Pharmacy Education, 25(1), 121-128.
Sammut Bartolo N, Vella Szijj J. Greenness, whiteness and blueness assessment of high-performance liquid chromatographic methods for determination of cannabinoids in cosmetics. Green Analytical Chemistry. 2025; 13:100250.
Tadic, I., Fialová, D., Hazen, A., Henman, M. C., Okuyan, B., Wirth, F.,… E. Weidmann, A. (2025). Current Practices on Prescribing and Deprescribing for Patients on Long-Term Antibiotic Treatment for Chronic Pulmonary Conditions: An Umbrella Review by the European Society of Clinical Pharmacy (ESCP). Journal of Chronic Obstructive Pulmonary Disease, 22(1), 2532076.
Vella, J., & Grech, L. (2025). Transition challenges in type 1 diabetes mellitus from paediatric to adult clinic. International Journal of Pharmaceutical Sciences and Research, 15(3), 720-726.
Weidmann, A. E., Cadogan, C., Fialová, D., Hazen, A., Henman, M. C., Okuyan, B.,... Nørgaard, L. S. (2025). Behavioural theories, models and frameworks to underpin clinical pharmacy and pharmacy practice research : guidance from the European Society of Clinical Pharmacy. International Journal of Clinical Pharmacy. https://doi.org/10.1007/s11096-025-01966-4.
Zammit Dimech, D., Grech, L., & Serracino-Inglott, A. (2025). Doctors’ and pharmacists’ perspectives on the clinical use of medicinal Cannabis: a cross-sectional study. Harm Reduction Journal, 22(1), 167.
Calleja, A., Szijj, J. V., Serracino-Inglott, A., & Azzopardi, L. M. (2024). Knowledge and perceptions about Cannabidiol use. Journal of Drug Delivery and Therapeutics, 14(1), 113-120.
Curtolo, E., Micallef, B., Szijj, J. V., Serracino-Inglott, A., & Borg, J. J. (2024). An exploratory study of knowledge, attitudes, practice and barriers towards adverse drug reaction reporting among healthcare professionals in Malta. International Journal of Risk & Safety in Medicine, 35, 271-286.
Patrocinio, Y.A.P., Vella Szijj, J., Serracino Inglott, A., & Azzopardi, L.M. (2024). The availability of medicines post-Brexit in Malta. Regulatory Rapporteur, 21(6), 1-20
Sammut Bartolo N, Gallo LL, Szyrner K, Buhagiar PI, Vella Szijj J. Greenness assessment of analytical methods for determination of cannabinoids in oils using NEMI, Analytical Eco-scale, AGREE and GAPI. Analytical Methods. 2024;16:5931-5942. Doi: https://doi.org/10.1039/
Vella Szijj, J. (2024). Challenges of extracting and determining cannabinoids in different matrices. Cannabis and Cannabinoid Research. DOI: 10.1089/can.2024.0087
Vella Szijj, J., Gallo, L. L., Buhagiar, P. I., Szyrner, K., Sammut Bartolo, N., Ronsisvalle, S.,... Azzopardi, L. M. (2024). Analysis of cannabinoids in oil. Integrative Medicine Reports, 3(1), 122-131
Wirth F, Cadogan CA, Fialová D, Hazen A, Lutters M, Paudyal V, et al. Writing a manuscript for publication in a peer-reviewed scientific journal: Guidance from the European Society of Clinical Pharmacy. Int J Clin Pharm. 2024. https://doi.org/10.1007/
Zaccomer, A., Wirth, F., Camilleri, L., & Azzopardi, L. M. (2024). Design and evaluation of a tool to assess the impact of interprofessional education on the development of pharmacy professional competencies. Pharmacy Education, 24(1), 529-538.
Busuttil CA, Wirth F, Azzopardi LM. Establishing a community pharmacist-led vitamin D point-of-care testing service. Journal of the American College of Clinical Pharmacy. 2023. doi: 10.1002/jac5.1867
Despott R, Sultana J, Camilleri L, Vella Szij J, Serracino Inglott A. Risk management of medication errors: a novel conceptual framework. Expert Opinion on Pharmacotherapy. 2023. doi: 10.1080/14656566.2023.2178899.
Etukakpan A, Uzman N, Ozer O, Tofade T, Leite SN, Joda A, et al. Transforming pharmaceutical education: A needs-based global analysis for policy development. Exploratory Research in Clinical and Social Pharmacy. 2023: (9);1-12.
Micallef, B., Dogné, J. M., Sultana, J., Straus, S. M., Nisticò, R., Serracino-Inglott, A., & Borg, J. J. (2023). An Exploratory Study of the Impact of COVID-19 Vaccine Spontaneous Reporting on Masking Signal Detection in EudraVigilance. Drug Safety, 46(11), 1089-1103
Murdan, S., Wei, L., van Riet-Nales, D. A., Gurmu, A. E., Usifoh, S. F., Tăerel, A. E.,...Furnham, A. (2023). Association between culture and the preference for, and perceptions of, 11 routes of medicine administration: A survey in 21 countries and regions. Exploratory Research in Clinical and Social Pharmacy, 12, 100378.
Parovincaka, J., Szijj, J. V., Serracino-Inglott, A., & Azzopardi, L. M. (2023). Cannabis for medicinal use in patients with rare diseases. Translational Science of Rare Diseases, 6(4), 123-135.
Paudyal V, Okuyan B, Henman MC, Stewart D, Lutters M, Oleárová A, et al. Scope, content and quality of clinical pharmacy practice guidelines: a systematic review. International Journal of Clinical Pharmacy. 2023. https://doi.org/10.1007/
Sammut Bartolo N, Vella Szijj J, Ferrito V, Serracino-Inglott A. HPLC-UV method development and validation to monitor difluprednate synthesis. Journal of Chromatographic Science. 2023
Tejada Rodriguez, E., Vella Szijj, J., Cachia, M., Falzon, P., Axisa, K., Serracino-Inglott, A., & Azzopardi, L.M. (2023). An efficient HPLC-UV method for determination of tetrahydrocannabinol in oil. Asian Journal of Pharmaceutical and Clinical Research, 16(3), 110-115
Von Brockdorff B, Azzopardi LM. Competencies for the position of the responsible person in good distribution practice Pharmacy Education. 2023; 23(1): 30-38.
Weidmann A, Cadogan C, Fialová D, Hazen A, Henman MC, Lutters M, et al. How to write a successful grant application: Guidance provided by the European Society of Clinical Pharmacy. Int J Clin Pharm. 2023. doi: 10.1007/s11096-023-01543-7
Antoniak KM, Vella Szijj J, Juurmaa J, Azzopardi LM. Inappropriate prescribing in patients with renal impairment. JPHSR 2022. [DOI]
Attard T, Azzopardi LM, Attard E.Daily facial skincare formulations : benefits and risks. Acta Polonia Pharmaceutica-Drug Research 2022; 79: 49-61.
Bleidt B, Doshi M, Abourashed E, Azzopardi LM, Upmanyu N. Career and continuing professional development opportunities for global pharmacists as educators. Pharmacy Education (2022 )22(4)32-33
Bruno Xuereb AM, Wirth F, Mifsud-Buhagiar L, Camilleri L, Azzopardi LM, Serracino-Inglott A. Pharmacist and physician perception of pharmacogenetic testing. Int J Pharm Pract. 2022;30(2):188-191.
Curtolo E, Vella Szijj, Camilleri L, Serracino-Inglott A, Azzopardi LM. Development, validation and evaluation of learning activities to support the reporting of adverse drug reactions during the COVID-19 pandemic. Pharmacy Education 2022; 22(1): 515-522.
Micallef B, Nistico R, Bjerrum OW, Sarach SB, Butler D, Serracino-Inglott, Borg JJ. Outcomes and endpoints in clinical trials supporting the marketing authorisation of treatments in paediatric acute lymphoblastic leukaemia. Drug Discovery Today 2022;. [DOI]
Micallef B, Nistico R, Sarac SB, Bjerrum OW, Butler D, Sammut Bartolo N, Serracino-Inglott A, Borg JJ. The changing landscape of treatment options in childhood acute lymphoblastic leukaemia. Drug Discovery Today 2022; 27(5): 1483-1494.
Mifsud Buhagiar L, Casha M, Grech A, Serracino-Inglott A, LaFerla G. The interplay between pharmacogenetics, concomitant drugs and blood levels of amitriptyline and its main metabolites. Personalised Medicine 2022; 19(2): 113-123.
Sammut Bartolo N, Grech V, Serracino-Inglott A, Azzopardi LM. Influenza and COVID-19 hesitancy in pharmacists and pharmacy students. MMJ 2022; 34: 58-68.
Scala D, Mucherino S, Wirth F, Orlando V, Polidori P, Faggiano ME, Iovine D, Saturnino P, Cattel F, Costantini A, Giua C, Makoul G, Azzopardi LM, Menditto E. Developing and piloting a communication assessment tool assessing patient perspectives on communication with pharmacists (CAT-Pharm). Int J Clin Pharm. 2022
Tanti, A., Micallef, B., Vella Szijj, J., Serracino-Inglott, A., & Borg, J. J. (2022). QT shortening: a proarrhythmic safety surrogate measure or an inappropriate indicator of it?. Current Medical Research and Opinion, 38(9), 1473-1483.
Vassallo, S., Attard Pizzuto, M., Azzopardi, L. M., & Serracino-Inglott, A. (2022). Rare diseases and orphan medicines: knowledge and perceptions of healthcare professionals and the public. Journal of Pharmaceutical Health Services Research, 13(4), 393-395.
Zaccomer A, Wirth F, Camilleri L, Azzopardi LM. Perception of interprofessional education among students following pharmacy studies. Journal of Pharmacy Practice. 2022.
Zuccarelli M, Micallef, B, Butler D, Serracino-Inglott A, Borg JJ. Improving the data quality of spontaneous ADR reports : a practical example from Malta. Expert Opinion on Drug Safety 2022; 21: 253-268.
Almojero DC, Vella Szijj J, Azzopardi LM, Serracino-Inglott A. Perspectives of practices related to the implementation of the FMD. Regulatory Rapporteur. 2021; 18(7/8): 29-32.
Butler D, Vucic K, Straus S, Cupelli A, Micallef B, Serracino-Inglott A, Borg JJ. Regulatory experience of handling Risk Management Plans (RMPs) for medicinal products in the EU. Expert Opinion on Drug Safety. 2021; 20(7): 815-826, DOI: 10.1080/14740338.2021.1909569
Falzon S, Galea N, Calvagna V, Pham JT, Grech L, Azzopardi LM. Development and use of an innovative Gap Finding Tool to create Pharmaceutical Care Model within a paediatric oncology setting. Journal of Oncology Pharmacy Practice. 2021;11: 1-9, doi:10.1177/10781552211053249
Kochova E, Vella Szijj J, Azzopardi LM. Price of medicines in a small market country : a comparative approach. Journal of Pharmaceutical Health Services Research. 2021; 20: 1-4.
Mantel-Teeuwisse AK, Meilianti S, Khatri B, Yi W, Azzopardi LM, Acosta Gómez J, Gülpınar G, Bennara K, Uzman N. Digital Health in Pharmacy Education: Preparedness and Responsiveness of Pharmacy Programmes. Educ. Sci. 2021; 11, 296. https://doi.org/10.3390/educsci11060296
Osama S, Wirth F, Zahra G, Barbara C, Xuereb RG, Camilleri L, Azzopardi LM. CYP2C19* 2 genetic polymorphism and incidence of in-stent restenosis in patients on clopidogrel: A matched case-control study. Drug Metabolism and Personalized Therapy, 2021 DOI: 10.1515/dmpt-2021-0160
Sammut Bartolo N, Azzopardi LM, Serracino-Inglott A. Pharmaceuticals and the environment. Early Human Development. 2021;155:105218. https://doi.org/10.1016/j.earlhumdev.2020.105218
Serracino-Inglott, A. How to think like Francke for a global vision in challenging times. American Journal of Health-System Pharmacy. 2021.
Tejada E, Vella Szijj J, Cachia M, Falzon P, Azzopardi LM, Serracino-Inglott A. Effects of pH and amount of acetonitrile on the separation of cannabinoids. Asian J Pharm Clin Res. 2021; 14(4): 70-6.
Tejada Rodríguez, E., Vella Szijj, J., Cachia, M., Falzon, P., Axisa, K., Serracino-Inglott, A. & Azzopardi, L.M. (2021). Development of an efficient analytical method to determine tetrahydrocannabinol in cannabidiol oil. AOAC Annual Meeting and Exposition, Boston.
Vella J, Attard Pizzuto M, Sammut Bartolo N, Wirth F, Grech L, Pham J, Mactal Haaf C, Lau A, Serracino-Inglott A, Azzopardi LM. A three-year post-graduate Doctorate in Pharmacy course incorporating professional, experiential and research activities: A collaborative innovative approach. MedEdPublish. 2021; 10(1): 1-14. https://doi.org/10.15694/mep.22021.000093.1
Von Brockdorff, B., & Azzopardi, L. M. (2021). Requirements for the good distribution practice of medicinal products. Regulatory Rapporteur, 18, 1-4.
Azzopardi LM, Serracino-Inglott A. An inter-professional approach towards understanding the science, myths and realities of COVID-19 pandemic. Pharmacy Education. 2020. 20(2) 33 - 34, https://doi.org/10.46542/pe.2020.202.3334.
Azzopardi LM, Serracino-Inglott A. Clinical pharmacy education and practice evolvement in Malta. Journal of the American College of Clinical Pharmacy. 2020. DOI: 10.1002/jac5.1280.
Sammut Bartolo N, Attard Pizzuto M, Wirth F, Vella Szijj J, Serracino-Inglott A, Azzopardi LM. The shift from class-based to online learning during COVID-19 : a student and academic perception. Pharmacy Education, 20(2), 290-296.
Sammut Bartolo N, Ignas L, Wirth F, Attard-Pizzuto M, Vella Szijj J, Camilleri L, Serracino-Inglott A, Azzopardi, LM. Public perception of generic medicines in Malta. Journal of Pharmaceutical Health Services Research. 2020;11(3):295-298. DOI: doi.org/10.1111/jphs.12366.
Sammut Bartolo N, Zoidis G, Gikas E, Benaki D, Ferrito V, Serracino-Inglott A. A multi-technique analytical approach for impurity profiling during synthesis: The case of difluprednate. J Pharm Biomed Anal. 2020;190:113483. doi:10.1016/j.jpba.2020.113483.
Zuccarelli M, Vella Szijj J, Serracino-Inglott A, Borg JJ. Treatment of Leber's Hereditary Optic Neuropathy: An Overview of Recent Developments. Eur J Ophthalmol 2020 Jun 19;1120672120936592. doi: 10.1177/1120672120936592.
Abbas A, Vella Szijj J, Azzopardi LM, Serracino-Inglott A. Orphan drug policies in different countries. Journal of Pharmaceutical Health Services Research 2019;10(3):295-302.
Attard Pizzuto M, Camilleri L, Azzopardi LM, Serracino-Inglott A. Exploring views of pharmacists on antibacterial prescribing: a Maltese perspective.International Journal of Pharmacy Practice. 2019; 27(3): 256-263.
Borg JJ, Melchiorri D, Sepodes B, Caramella CM, Tomino C, Micallef B, Serracino-Inglott A, Nistico R. Optimising Bench Science to Withstand Regulatory Scrutiny. Pharmacological Research 2019; 139: 491–493.
Gauci M, Wirth F, Azzopardi LM, Serracino-Inglott A. Clinical pharmacist implementation of a medication assessment tool for long-term management of atrial fibrillation in older persons. Pharmacy Practice. 2019; 17(1): 1349.
Mifsud EM, Wirth F, Camilleri L, Azzopardi LM, Serracino-Inglott A. Pharmacist-led medicine use review in community pharmacy for patients on warfarin. Int J Clin Pharm. 2019;41(3):741-750.
Mifsud Buhagiar L, Casha M, Grech A, Micallef B, Borg JJ, Serracino-Inglott A, LaFerla G. Safety Implications of Low-Dose Amitriptyline in Neuropathic Pain. Pharm Front. 2019;1:e190003. https://doi.org/10.20900/pf20190003
Mifsud Buhagiar L, Micallef B, Borg JJ, Vella H, Serracino-Inglott A, Laferla G. Regulatory sciences and translational pharmacogenetics: amitriptyline as a case in point. Drug Metabolism and Personalized Therapy, Volume 34, Issue 2, 20190005, ISSN (Online) 2363-8915, DOI: https://doi.org/10.1515/dmpt-2019-0005
Mifsud Buhagiar L, Sammut C, Chircop Y, Axisa K, Sammut Bartolo N, Vella Szijj J, Serracino-Inglott A, LaFerla G. Practical liquid chromatography–tandem mass spectrometry method for the simultaneous quantification of amitriptyline, nortriptyline and their hydroxy metabolites in human serum. Biomedical Chromatography. 2019; 33(12), e4679. doi: 10.1002/bmc.4679.
Pham JT, Azzopardi LM, Lau AH, Jarrett JB. Student Perspectives on a Collaborative International Doctorate of Pharmacy Program. Pharmacy 2019; 7(3): 85-92.
Aquilina A, Wirth F, Attard Pizzuto M, Grech L, Camilleri, L, Azzopardi LM et al. Preparing for pharmacist prescribing in Maltese hospitals. Journal of Pharmaceutical Health Services Research 2018.
Borg JJ, Serracino-Inglott A, Al-Haddad D. A Review of the National Adverse Drug Reaction (ADR) & Medication Errors Reporting System of Malta. Malta Medical School Gazette. 2018; 2(1): 4-10.
Chetcuti M, Serracino-Inglott A, Flores G, Borg JJ. Pharmaceutical issues during the review of European Marketing Authorisation Applications in Malta. Pharmaceutical Development and Technology 2018; 23(6): 561-572.
Farrugia D, Cilia M, Serracino-Inglott A. Analysis of Good Distribution Practice Inspection Deficiency Data of Pharmaceutical Wholesalers in Malta. The Journal of Pharmaceutical and Biopharmaceutical Contract Services. Sep/Oct 2018; 30-32.
Gauci M, Wirth F, Azzopardi LM, Serracino-Inglott A. Clinical pharmacist implementation of a medication assessment tool for secondary prevention of stroke in older persons. Journal of Pharmaceutical Health Services Research 2018.
Mifsud-Buhagiar L, Scorpiniti M, Sammut Bartolo N, Vella Szijj J, Ferrito V, Serracino-Inglott A, LaFerla G. Implications of mobile phase composition and pH on the chromatographic separation of amitriptyline and its metabolite nortriptyline. Int J Pharm Pharm Sci, 2018; 10(4):132-8
Vella J, Wirth F, Azzopardi LM, Serracino-Inglott A. Serum digoxin concentrations: A retrospective analysis. J Pharmacol Clin Toxicol 2018; 6(7):1129 (5 pages).
Wirth F, Zahra G, Xuereb RG, Barbara C, Camilleri L, Fenech A et al. CYP2C19 *2 allele carrier status and coronary in-stent restenosis: Is there an association? J Explor Res Pharmacol 2018;3(2):55-60.
Wirth F, Zahra G, Xuereb RG, Barbara C, Camilleri L, Fenech A, et al. CYP2C19 genetic polymorphisms in Maltese patients on clopidogrel therapy. MMJ. 2018; 30 (2): 14-20.
Cilia M, Ruiz S, Richardson P, Salmonson T, Serracino-Inglott A, Wirth F et al. Quality Issues Identified During the Evaluation of Biosimilars by the European Medicines Agency’s Committee for Medicinal Products for Human Use. AAPS PharmSciTech 2017: 1-23.
Ellul C, Shoemake C. Design of Novel Compounds with the Potential of Dual PPARγ/α Modulation for the Management of Metabolic Syndrome. Nuclear Receptor Research 2017; 4.
Gauci M, Wirth F, Camilleri L, Azzopardi LM, Serracino-Inglott A. Design and application of a medication assessment tool for secondary prevention of stroke. Int J Clin Pharm. 2017; 39 (5): 1008-1012.
Gauci M, Wirth F, Camilleri L, Azzopardi LM, Serracino-Inglott A. Assessing appropriateness of drug therapy in older persons: Development and application of a medication assessment tool for long-term management of atrial fibrillation. Pharmacy Practice 2017 Oct-Dec;15(4):1021.
Gusman DH, Shoemake C. Evaluation and Optimization of in silico designed Sphingosine-1-Phosphate (S1P) Receptor Subtype 1 Modulators for the Management of Multiple Sclerosis. Yale J Biol Med. 2017 Mar; 90(1): 15–23.
Sultana G, Shoemake C, Camilleri L. Compilation, Validation and Evaluation of a 2D/3D Molecular Database as an Adjunct to Didactic Teaching Modalities. Literacy Information and Computer Education Journal (LICEJ) 2017; 8(2): 2553-2561.
Woods M, Shoemake C. Design and Optimization of K-Ras Protein Inhibitors as Anti-Cancer agents using Deltarasin as a Case Study. American Journal of Pharmacy and Health Research 2017; 5(7): 73-81.
Attard D, Shoemake C, Vella J, Żmudzki P, Chłoń-Rzepa G, Wyska E. Evaluation and Optimization of In Silico Designed PDE4B Modulators. American Journal of PharmTech Research. 2016; 6(5).
Attard Pizzuto M, Serracino-Inglott A, Azzopardi LM. Practices and Perceptions of Medical Practitioners on Potential Antibiotic Prescribing by Pharmacists. Journal of Pharmaceutical Health Services Research 2016; 7: 157-64.
Bonavia S, Shoemake C. Design and optimisation of novel Huperzine A analogues capable of modulating the acetylcholinesterase receptor for the management of Alzheimer’s disease. Journal of Pharmacognosy and Phytotherapy 2016; 8(5): 99-108.
Borg L, Xuereb K, Shoemake C. Evaluation and Optimization of In Silico Designed β-Secretase Modulators for the Treatment of "Alzheimer's Disease". AJPHR 2016; 4(10): 102-104.
Grech L, Ferrito V, Camilleri L, Serracino-Inglott A, Azzopardi LM. Pharmaceutical Care Models, Tools for Treating Patients with Rheumatoid Arthritis. The Rheumatologist 2016.
Mercieca M, Schembri F, Serracino-Inglott A, Azzopardi LM. Concept Design for Establishing an Eco-Friendly Pharmaceutical Production Facility in Malta. Pharmaceutical Technology 2016; 40(4): 38-49.
Sciberras R, Shoemake C. Optimization of In Silico Designed Fatty Acid Synthase Modulators Derived From the Lead Molecule Orlistat. Imperial Journal of Interdisciplinary Research (IJIR) 2016; 2(9): 1808-14.
Wirth F, Zahra G, Xuereb RG, Barbara C, Fenech A, Azzopardi LM. Comparison of a rapid point-of-care and two laboratory-based CYP2C19*2 genotyping assays for personalisation of antiplatelet therapy. Int J Clin Pharm 2016;38(2):414–420.
Borg JJ, Anker SD, Rosano G, Serracino-Inglott A, Strasser F. Multimodal management as requirement for the clinical use of anticachexia drugs - a regulatory and a clinical perspective. Curr Opin Support Palliat Care 2015; 9(4): 333-45.
Borg JJ, Tanti A, Kouvelas D, Lungu C, Pirozynski M, Serracino-Inglott A, Aislaitner G. European Union pharmacovigilance capabilities: potential for the new legislation. Ther Adv Drug Saf. 2015. Ther Adv Drug Saf. 2015; 6(4): 120-40.
Bugeja A, Attard Pizzuto M, Serracino-Inglott A, Azzopardi LM. Pharmacist intervention in a psychiatric setting. Eur J Hosp Pharm 2015; 0:1–5. doi:10.1136/ejhpharm-2014-000564
Bugeja NJ, Shoemake CM. Generating a Homology Model of the Human M1 Muscarinic Receptor and the Design of Cognate Modulators at this Locus for the Management of Alzheimer’s Disease. 2015; 6(9): 86-91.
Busuttil-Griffin F, Shoemake C, Attard E, Azzopardi LM. Crude Fibre Determination of Malva sylvestris L. and Evaluation of its Faecal Bulking and Laxative Properties in Rats. International Journal of Biology 2015; 7(4).
Camilleri A, Serracino-Inglott A, Azzopardi LM. Extemporaneous Preparations from the Past. Pharmaceutical Historian 2015; 45(2): 41-44.
Caruana C, Shoemake C. A Structure-Based Drug Design Approach for the Identification of Novel Selective Cyclooxygenase-2 Inhibitors using Resveratrol Analogues as Lead Molecules. BioMirror 2015; 6(10): 100-113.
Grech L, Ferrito V, Serracino-Inglott A, Azzopardi LM. 2015. Development and validation of RhMAT, as medication assessment tool specifically designed for rheumatoid arthritis management. Journal of Pharmaceutical Health Services Research 2015.
Magro L, Shoemake C, Serracino-Inglott A, Azzopardi LM. Chemical Enhancement of Fingerprints on Various Porous and Non-Porous Surfaces. Indian Journal of Forensic Medicine & Toxicology 2015; 9(1):225.
Micallef B, Attard E, Serracino-Inglott A, Borg JJ. 2015. Could EU herbal monographs contribute to Malta’s treatment armamentarium? Phytomedicine 2015; 22(3): 400–405.
Portelli G, Shoemake CM. The Design and Optimisation of Novel Human Dihydrofolate Reductase Inhibitors for the Management of Proliferative Disease. 2015; 6(9): 92-99.
Tanti A, Serracino-Inglott A, Borg JJ. Designing a national combined reporting form for adverse drug reactions and medication errors. East Mediterr Health J. 2015.
Ungaro S, Wirth F, Azzopardi LM, Serracino-Inglott A. Point-of-Care Testing for Urine Analysis and Microalbuminuria for Diabetic Patient Management. Point of Care: The Journal of Near-Patient Testing & Technology. 14(3):71-72, September 2015.
Vella J, Busuttil F, Sammut Bartolo N, Sammut C, Ferrito V, Serracino-Inglott A, Azzopardi LM, Laferla G. A simple HPLC–UV method for the determination of ciprofloxacin in human plasma. Journal of Chromatography 2015; 989: 80–85.
Vella J, Vella M, Cassar K, Camilleri L, Serracino-Inglott A, Azzopardi LM, Laferla G. Factors affecting penetration of ciprofloxacin in lower extremity ischemic tissues. Int J Lower Extremity Wounds 2015.
Vella M, Grima M, Wirth F, Attard Pizzuto M, Sammut Bartolo N, Vella J, Azzopardi LM. Consumer perception of community pharmacist extended professional services. Journal of Pharmaceutical Health Services Research 2015; 6(2): 91–96.
Agius Decelis D, Zarb Adami M, Galea J, Attard-Pizzuto M, Serracino-Inglott A, Azzopardi LM. Pharmacist intervention in pain management following heart surgery. Eur J Hosp Pharm published online 10 Sept 2014.
Brincat A, Azzopardi LM, Zarb Adami M, Serracino-Inglott A. Development and evaluation of a Drug Information Bulletin. JPHSR 2014; 5(2): 81–88.
Brincat Ruffini L, Azzopardi LM, Serracino-Inglott A. Perception of Use of Liquid Capsules. The Synapse published online 13 Oct 2014.
Mamo M, Wirth F, Azzopardi LM, Serracino-Inglott A. Standardising pharmacist patient-profiling activities in a rehabilitation hospital in Malta. Eur J Hosp Pharm 2014; 21:49-53.
Mason G, Wirth F, Cignarella A, Xuereb RG, Azzopardi LM. Antiplatelet and anticoagulant therapy for non-ST-elevation acute coronary syndromes in a general hospital. The Online Journal of Clinical Audits 2014; 6(3): 8-16.
Mifsud EM, Azzopardi LM, Serracino-Inglott A. Proposing a Framework for International Normalized Ratio Testing and Anticoagulation Management in Community Pharmacies. Point of Care: The Journal of Near-Patient Testing and Technology 2014; 13(4): 125–127.
Mifsud M, Vella J, Ferrito V, Serracino-Inglott A, Azzopardi LM, Sammut Bartolo N, LaFerla G, Sammut C. A simple HPLC-UV method for the determination of clindamycin in human plasma. Journal of Chemical and Pharmaceutical Research, 2014, 6(1): 696-704.
Portelli S, Shoemake C, Azzopardi LM. In Silico Identification Of A Potentially Novel Binding Modality For 1,3-Dicarbonyl Compounds Having 2(3H)-Benzazolonic Heterocycles Within The PPARγ Ligand Binding Pocket: A De Novo Design Study. BioMirror 2014; 5(1): 1-7.
Schembri M, Shoemake C, Sant-Fournier MA. Drug Design of Novel Molecules Using a Bioisosteric and De Novo Techniques - A comparison. BioMirror 2014; 5(9): 59-68.
Vella J, Mifsud M, Sammut Bartolo N, Ferrito V, Serracino-Inglott A, Azzopardi LM, Laferla G. The combined effects of pH and acetonitrile composition on the separation of two lincosamide antibiotics. Asian Journal of Pharmaceutical and Clinical Research 2014; 7(5): 96-100.
Zammit M, Shoemake C, Attard E, Azzopardi LM. The Effects of Anabasine and the Alkaloid Extract of Nicotiana glauca on Lepidopterous Larvae. International Journal of Biology 2014; 6(3): 47-53.
Aquilina S, Azzopardi LM, Serracino-Inglott A. Impacting Cardiovascular Disease Risk Management. Hospital Pharmacy Europe 2013; 68.
Baldacchino S, Camilleri L, Fava S, Serracino-Inglott A, Azzopardi LM. Risk Assessment Models for the Development of Complications in Maltese Type 2 Diabetic Patients. J Diabetes Metab 2013; 4(2): 1-6.
Captur C, Azzopardi LM, Serracino-Inglott A. Health-related quality of life and hormone replacement therapy. Hospital Pharmacy Europe 2013; 70.
Cassar M, Shoemake C, Azzopardi LM, Saliba C, Gutierrez G. de novo Design of Non-Steroidal Oestrogen Receptor Modulating Molecules using Maltanedienol as a Lead Molecule. International Journal of Drug Design and Discovery 2013; 4(1): 965-977.
Farrugia DL, Shoemake CM, Attard E, Azzopardi LM, Mifsud SJ. Investigative study on the angiotensin converting enzyme (ACE) inhibiting properties of the terpenoid extract of Crataegus monogyna using in silico models. Journal of Pharmacognosy and Phytotherapy 2013; 5(2): 34-37.
Galea S, Zarb Adami M, Serracino-Inglott A, Azzopardi LM. Pharmacist interventions in non-prescription medicine use. Journal of Pharmaceutical Health Services Research 2013.
Grech L, Coleiro B, Borg A, Serracino-Inglott A, Azzopardi LM. Evaluation of the Impact of A Pharmaceutical Care Service Offered to Rheumatoid Arthritis Patients Within an Ambulatory Setting. American Journal of Pharmacy and Health Research 2013; 1(7): 2321–3647.
Mercieca C, Serracino-Inglott A, Azzopardi LM. Perceptions of a newsletter for community pharmacists. Journal of Pharmaceutical Health Services Research 2013; 4(2): 101-103.
Micallef C, Shoemake C, Azzopardi LM. Creating a high-throughput screening database to propose ligands capable of modulating the HIV-1 protease receptor. Journal of AIDS and HIV Research 2013; 5(7): 224-234.
Mifsud-Buhagiar L, Cassar OA, Brincat MP, Buttigieg GG, Serracino-Inglott A, Zarb-Adami M, Azzopardi LM. Pre‑operative pain sensitivity: A prediction of post‑operative outcome in the obstetric population. Journal of Anaesthesiology Clinical Pharmacology 2013; 29(4): 465-471.
Muscat Terribile C, Wirth F, Zammit MC, Vella J, Azzopardi LM, Serracino-Inglott A. Evaluation of a Quality System Developed for Pharmacy Teaching Laboratories. Pharmacy Education, 2013; 13 (1): 134 - 139.
Pace A, Azzopardi LM, Serracino-Inglott A, Wismayer L, Zarb Adami M. Development in the European Union and Access to Medicines. Pharmacie Globale (IJCP) 2013; 4(6): 1-7.
Pace Bardon C, Shoemake C, Azzopardi LM, Serracino-Inglott A. Investigating the Anti-Oestrogenic Effect of p-Synephrine and de novo design of Oestrogen Receptor Modulating Molecules. BioMirror 2013; Volume 4(8): 5-12.
Said C, Coleiro B, Zarb-Adami M, Azzopardi LM, Serracino-Inglott A. Cost Effectiveness of TNF-α Inhibitors in Rheumatoid Arthritis. International Journal of Inflammation 2013.
Spiteri M, Attard E, Serracino-Inglott A, Azzopardi LM. Compilation of a herbal medicine formulary for herbal substances in Malta and its usefulness amongst healthcare professionals. Journal of Young Pharmacists 2013; 5: 22-25.
Ciantar J, Shoemake C, Mangani C, Azzopardi LM, Serracino Inglott A. Optimisation of Tyrosine-based Lead Molecules capable of modulation of the Peroxisome proliferator-activated receptor gamma. International Journal of Pharmaceutical Sciences and Research 2012; 3(8): 2550-2561.
Grima A, Shoemake C, Azzopardi LM, Serracino Inglott A. Optimisation of Abiraterone Based Non-Steroidal Lead Molecules. BioMirror 2012; 3(9): 1-8.
Sapiano K, Savona-Ventura C, Calleja-Agius J, Serracino-Inglott A, Azzopardi LM. Attitudes towards preconception care in Maltese women with type 1 diabetes mellitus. Gynecol Endocrinol. 2012;28(12):1006-9.
Buhagiar L, Cassar OA, Brincat MP, Buttigieg GP, Serracino-Inglott A, Zarb-Adami M, Azzopardi LM. Predictors of post-caesarean section pain and analgesic consumption. Journal of Anaesthesiology Clinical Pharmacology 2011; 27 (2): 185-191.
Fenech J, Galea R, Serracino-Inglott A, Azzopardi LM. Management and Patient Knowledge of Osteoporosis. Journal of Applied Therapeutic Research 2011; 8: 101-106.
Pirotta I, Serracino-Inglott A, Azzopardi LM, Anastasi A. Patient knowledge of colorectal cancer therapy side effects. Hospital Pharmacy Europe 2011; 58: 24-26.
Sacco R, Azzopardi LM, Serracino-Inglott A. Palliative care in cancer patients: evaluating pharmacist intervention in a hospice setting. European Journal of Hospital Pharmacy 2011; 17(3): 75-80.
Zammit MC, Fiorentino L, Cassar K, Azzopardi LM, LaFerla G. Factors Affecting Gentamicin Penetration in Lower Extremity Ischemic Tissues With Ulcers. International Journal of Lower Extremity Wounds. 2011. Aug. 19.
Griscti S, Serracino-Inglott A, Zarb-Adami M, Azzopardi LM, Mallia C, Azzopardi L, Camilleri Vassallo F, Cassar PJ, Coleiro B, Cassar K, Aquilina D, Anastasi A. Management of rheumatoid arthritis. Hospital Pharmacy Europe March/April 2010; 49: 20-21.
Pizzuto M, Portelli J, Serracino-Inglott A, Zarb-Adami M, Azzopardi LM. Chronopharmacology of antihypertensives. Journal of Applied Therapeutic Research. 2010; 7(4):133-140.
Wirth F, Tabone F, Azzopardi LM, Gauci M, Zarb Adami M, Serracino Inglott A. Consumer perception of the community pharmacist and community pharmacy services in Malta. Journal of Pharmaceutical Health Services Research 2010; 1(4): 189-194.
Zammit G, Farrugia R, Barbara C, Azzopardi LM, Serracino-Inglott A, Zarb-Adami M, Grech V. Anticoagulation services in Malta – an economic study comparing a central laboratory model vs. a point-of-care approach. Int. Jnl. Lab. Hem. 2010. Dec. 1-2.
Conti L, Wirth F, Azzopardi L, Mallia C, Camilleri Vassallo F, Coleiro B, Cassar PJ, Cassar K, Azzopardi LM, Zarb-Adami M, Serracino-Inglott A. Pharmaceutical care aspects in systemic lupus erythematosus. Hospital Pharmacy Europe. March/April 2009; 43: 48-51.
Manduca E, Azzopardi LM, Manche A, Zarb-Adami M, Serracino-Inglott A. Tolerance to an 8mg dose of perindopril for secondary prevention of coronary artery disease. Hospital Pharmacy Europe 2009.
Pizzuto M, Wirth F, Azzopardi LM, Zarb Adami M, Serracino-lnglott A. Palliative care in cancer patients. Hospital Pharmacy Europe 2009; 42: 66-69.
Vella E, Azzopardi LM, Zarb-Adami M, Serracino-Inglott A. Development of protocols for the provision of headache and back-pain treatments in Maltese community pharmacies. Int J Pharm Pract 2009; 17: 269-274.
Wirth F, Azzopardi LM, Gauci M, Zarb-Adami M, Serracino-Inglott A. Time and motion study for pharmacists’ activities in a geriatric hospital. Int J Pharm Pract 2009; 17: 373-376.
Aquilina S, Azzopardi LM, Zarb-Adami M, Serracino-Inglott A. Disease management in community pharmacy. Hospital Pharmacy Europe 2008.
Azzopardi LM. Medications management in older persons: What can be achieved in the international community? Home Health Care Services Quarterly 2005; 24:137-146.
Azzopardi LM, Serracino-Inglott A, Salek S, Zarb-Adami M. Development of external methods to evaluate the quality of pharmacy services offered by community pharmacists. Quality Assurance Journal 2003; 7(4):248-2257.
Azzopardi LM, Salek S, Serracino-Inglott A, Zarb-Adami M, Buhagiar A. Validating tools for the monitoring of community pharmacy services. Pharmaceutical Journal 2001;267,303-305.
Micallef MJ, Darmanin S, Buhagiar JA, Camilleri-Podesta MT, Yamauchi H, Kurimoto M, et al. Interferon gamma induction in human melanoma cell/allogeneic leukocyte co-cultures is enhanced by interleukin 18 but drug resistant melanoma cells are poorer inducers of IFN-γ. International Immunopharmacology 2001;1(2),295-305.
Azzopardi LM, Salek S, Serracino-lnglott A, Zarb-Adami M. Development of external validation tools for community pharmacy. Pharmaceutical Journal 1998; 161, R49.
Serracino-Inglott A, Farrugia S, Ferrito MN. Prevalence and Drug Treatment of the Parkinsonian Syndrome in Malta. Dement Geriatr Cogn Disord 1992; 3(1): 47–57.
Kramer, W., Serracino-Inglott, A., Cluxton, R. Some physical and chemical incompatibilities of drugs for IV administration. Drug Intelligence & Clinical Pharmacy 1971; 5(7), 211-228.